These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1031 related articles for article (PubMed ID: 25127423)

  • 41. Catheter-related infections caused by Pseudomonas aeruginosa: virulence factors involved and their relationships.
    Olejnickova K; Hola V; Ruzicka F
    Pathog Dis; 2014 Nov; 72(2):87-94. PubMed ID: 24842562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotic resistance, virulence factors and genotyping of Pseudomonas aeruginosa in public hospitals of northeastern Mexico.
    González-Olvera EM; Pérez-Morales R; González Zamora A; Castro-Escarpulli G; Palma-Martínez I; Alba-Romero JJ
    J Infect Dev Ctries; 2019 May; 13(5):374-383. PubMed ID: 32053506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
    Mohanty S; Maurya V; Gaind R; Deb M
    J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF; El-Domany RA; Zaki S; Ashour HM
    J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RT-PCR detection of exotoxin genes expression in multidrug resistant Pseudomonas aeruginosa.
    Tartor YH; El-Naenaeey EY
    Cell Mol Biol (Noisy-le-grand); 2016 Jan; 62(1):56-62. PubMed ID: 26828988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
    Fournier D; Richardot C; Müller E; Robert-Nicoud M; Llanes C; Plésiat P; Jeannot K
    J Antimicrob Chemother; 2013 Aug; 68(8):1772-80. PubMed ID: 23587654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extended-spectrum and metallo-beta-lactamases among ceftazidime-resistant Pseudomonas aeruginosa in Riyadh, Saudi Arabia.
    Al-Agamy MH; Shibl AM; Tawfik AF; Elkhizzi NA; Livermore DM
    J Chemother; 2012 Apr; 24(2):97-100. PubMed ID: 22546765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
    Rojo-Bezares B; Estepa V; Cebollada R; de Toro M; Somalo S; Seral C; Castillo FJ; Torres C; Sáenz Y
    Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenotypic characterization of multidrug-resistant Pseudomonas aeruginosa strains isolated from pediatric patients associated to biofilm formation.
    Ochoa SA; Cruz-Córdova A; Rodea GE; Cázares-Domínguez V; Escalona G; Arellano-Galindo J; Hernández-Castro R; Reyes-López A; Xicohtencatl-Cortes J
    Microbiol Res; 2015 Mar; 172():68-78. PubMed ID: 25530579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
    Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
    J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterisation of potential virulence markers in Pseudomonas aeruginosa isolated from drinking water.
    Silva ME; Filho IC; Endo EH; Nakamura CV; Ueda-Nakamura T; Filho BP
    Antonie Van Leeuwenhoek; 2008 May; 93(4):323-34. PubMed ID: 18038252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia.
    Lim KT; Yasin RM; Yeo CC; Puthucheary SD; Balan G; Maning N; Wahab ZA; Ismail N; Tan EA; Mustaffa A; Thong KL
    J Microbiol Immunol Infect; 2009 Jun; 42(3):197-209. PubMed ID: 19812853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular characterization of
    Arfaoui A; Rojo-Bezares B; Fethi M; López M; Toledano P; Sayem N; Ben Khelifa Melki S; Ouzari HI; Klibi N; Sáenz Y
    J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 38963417
    [No Abstract]   [Full Text] [Related]  

  • 54. Phenotypic and genotypic diversity of multidrug-resistant Pseudomonas aeruginosa Isolates from bloodstream infections recovered in the Hospitals of Belo Horizonte, Brazil.
    Inacio HS; Bomfim MR; França RO; Farias LM; Carvalho MA; Serufo JC; Santos SG
    Chemotherapy; 2014; 60(1):54-62. PubMed ID: 25402327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections.
    Tielen P; Narten M; Rosin N; Biegler I; Haddad I; Hogardt M; Neubauer R; Schobert M; Wiehlmann L; Jahn D
    Int J Med Microbiol; 2011 Apr; 301(4):282-92. PubMed ID: 21193347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
    Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
    Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production of metallo-β-lactamase among Pseudomonas aeruginosa strains isolated in the State of Sergipe, Brazil.
    Costa LM; Fleming ME; Paula GR; Teixeira LA; Mondino PJ; de Mondino SS; Mendonça-Souza CR
    Rev Soc Bras Med Trop; 2015; 48(2):212-5. PubMed ID: 25992939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emergence of metallo-β-lactamase IMP-14 and VIM-2 in Pseudomonas aeruginosa clinical isolates from a tertiary-level hospital in Thailand.
    Piyakul C; Tiyawisutsri R; Boonbumrung K
    Epidemiol Infect; 2012 Mar; 140(3):539-41. PubMed ID: 21733273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem.
    Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A
    J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.